Vincristine, DOXIL® (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
This study has been completed.
Study NCT00344422
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: June 23, 2006
Last Updated: March 17, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
